Receptor tyrosine kinase erbB2, which is activated by neuregulin, is expres
sed in Schwann and muscle cells in the developing neuromuscular junction (N
MJ). in vitro studies have shown that neuregulin promotes the survival and
migration of Schwann cells and stimulates acetylcholine receptor gene trans
cription in cultured muscle cells. These findings suggest an important role
for erbB2 in the development of the NMJ. Here we examine erbB2-deficient m
ice to determine whether erbB2 is required for NMJ development in vivo. Our
analysis shows that there are pre- and postsynaptic defects of developing
NMJ in erbB2-deficient embryos. The presynaptic defects include defascicula
tion and degeneration of the motor nerves, and an absence of Schwann cells.
The postsynaptic defect features an impairment of junctional folds at the
neuromuscular synapse in the mutants. These results demonstrate that erbB2
is essential for in vivo development of the NMJ.